FY2021 EPS Estimates for Tilray Inc Decreased by Analyst (NASDAQ:TLRY)
Tilray Inc (NASDAQ:TLRY) – Equities researchers at Seaport Global Securities cut their FY2021 EPS estimates for shares of Tilray in a research note issued to investors on Tuesday, June 11th. Seaport Global Securities analyst B. Hundley now forecasts that the company will earn $0.39 per share for the year, down from their prior forecast of $0.51. Seaport Global Securities currently has a “Neutral” rating and a $81.10 price target on the stock.
TLRY has been the topic of a number of other research reports. Vertical Group assumed coverage on Tilray in a research report on Friday, April 12th. They set a “sell” rating on the stock. Jefferies Financial Group raised Tilray from an “underperform” rating to a “hold” rating and dropped their price target for the company from $61.00 to $57.00 in a research report on Friday, May 3rd. Roth Capital reaffirmed a “hold” rating on shares of Tilray in a research report on Thursday, March 21st. Piper Jaffray Companies set a $90.00 price objective on Tilray and gave the stock a “buy” rating in a report on Tuesday, March 19th. Finally, Zacks Investment Research cut Tilray from a “hold” rating to a “sell” rating in a report on Thursday, April 25th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. Tilray presently has an average rating of “Hold” and an average target price of $79.57.
Tilray (NASDAQ:TLRY) last issued its quarterly earnings results on Tuesday, May 14th. The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.02). Tilray had a negative net margin of 159.09% and a negative return on equity of 43.71%. The firm had revenue of $23.00 million for the quarter, compared to analysts’ expectations of $20.50 million. The firm’s revenue was up 194.9% on a year-over-year basis.
In other Tilray news, CFO Mark Castaneda sold 10,000 shares of the firm’s stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $51.72, for a total value of $517,200.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CRO Edward Wood Pastorius, Jr. sold 3,443 shares of the firm’s stock in a transaction dated Friday, April 5th. The shares were sold at an average price of $61.04, for a total value of $210,160.72. The disclosure for this sale can be found here. Insiders have sold a total of 166,109 shares of company stock worth $10,409,698 in the last three months. 3.40% of the stock is currently owned by insiders.
Several large investors have recently added to or reduced their stakes in TLRY. Lee Financial Co purchased a new stake in shares of Tilray in the 1st quarter valued at about $25,000. Quantamental Technologies LLC purchased a new stake in shares of Tilray in the 1st quarter valued at about $26,000. Toronto Dominion Bank purchased a new stake in shares of Tilray in the 4th quarter valued at about $27,000. PNC Financial Services Group Inc. raised its holdings in shares of Tilray by 105.8% in the 1st quarter. PNC Financial Services Group Inc. now owns 463 shares of the company’s stock valued at $30,000 after acquiring an additional 238 shares in the last quarter. Finally, Kore Private Wealth LLC purchased a new stake in shares of Tilray in the 1st quarter valued at about $41,000. 2.04% of the stock is currently owned by hedge funds and other institutional investors.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Featured Story: Trading Strategy Examples and Plans
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.